Investor Fact Sheet

Home » Investors » Investor Fact Sheet

We aim to make a contribution to the evolution of scientific research using our skills, technology and experience to find solutions to the world’s most complex challenges.We harness the power of science and technology to deliver integrated innovation with pace and efficiency across a diverse range of scientific domains. By providing access to the latest technology and highly trained scientists, underpinned by our values of integrity, excellence and professionalism, our aim is to be a trusted partner for clients seeking to explore the boundaries of science at affordable cost. Our services span the value chain from discovery to the clinic. Beyond the science, our strengths lie in our relentless pursuit of operational excellence; flexible business models; investment in data integrity; and passion for quality. We are proud to have partnerships that are deeply founded and nurtured over the years, delivering a level of commitment and understanding that drives innovation and scientific advances, thus linking our success to that of our clients and the people and patients they serve.

Key Figures (Consolidated, INR Million)

	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue from operations	14,231	18,256	20,119	21,843	26,042	31,929	34,886	36,424	37,387
Other Income	618	751	816	646	528	709	906	718	707
Total income	14,849	19,007	20,935	22,489	26,570	32,638	35,792	37,142	38,094
Total expenses	9,583	12,888	13,940	15,125	18,081	22,585	24,742	26,006	28,202
EBITDA	5,266	6,119	6,995	7,364	8,489	10,053	11,050	11,136	9,892
EBITDA Margin %	35.5	32.2	33.4	32.7	31.9	30.8	30.9	30.0	26.0
Depreciation	1,314	1,642	2,193	2,745	3,097	3,665	4,259	4,326	4,529
Finance Cost	227	323	346	277	241	452	472	531	488
Profit Before Tax	3,725	4,154	4,456	4,342	5,151	5,936	6,319	6,279	4,875
Tax	671	838	794	521	940	1,292	1,133	1,530	1,076
Profit After Tax before exceptional items	3,054	3,316	3,662	3,821	4,211	4,644	5,186	4,749	3,799
Exceptional Items (net of tax)			459	228	-253	–	-86	213	-632
Profit After Tax after exceptional items	3,054	3,316	4,121	4,049	3,958	4,644	5,100	4,962	3,167
Total Paid up Share Capital	2,000	2,000	4,000	4,000	4,008	4,014	4,020	4,025	4,029
Bonus Declared	–	–	0.04	–	–	–	–	–	–
Net cash from operating activities	4,462	6,304	6,771	7,012	5,806	8,235	10,421	11,676	9,152
Net cash from investing activities	-3,493	-6,465	-4,284	-6,281	-6,115	-6,564	-4,956	-7,447	-8,604
Net cash from financing activities	-787	-724	-2,255	580	-313	-3,425	-5,515	-1,418	-2,150
Total Cash Flow	182	-885	232	1,311	-622	-1,754	-50	2,811	-1,602
Effect of exchange difference on cash and cash equivalents held in foreign currency	–	10	46	-8	7	31	11	3	217
Cash and cash equivalents at the end of the year	2,527	1,652	1,930	3,233	2,618	895	857	3,671	2,286*
Dividend Per Share (incl. interim and final dividends)	0.50	1.00	–	–	0.50	1.25	1.25	1.25	1.25